BioCentury
ARTICLE | Financial News

Supernus planning follow-on

November 15, 2012 12:46 AM UTC

Supernus Pharmaceuticals Inc. (NASDAQ:SUPN) is planning to raise up to $86.3 million in a follow-on underwritten by Jefferies; Piper Jaffray; Cowen; Stifel Nicolaus Weisel; and Lazard. Supernus, which raised $50 million in a May IPO, was off $1.11 to $11.54 on Wednesday. ...